Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050

Grading quality of evidence and strength of recommendations

(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477

Bariatric Surgery: A Systematic Review and Meta-analysis

Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457

Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS

Смирнов, В. В., Beeraka, N. M., Butko, D. Y., Nikolenko, V. N., Bondarev, S., Achkasov, E. E., Sinelnikov, M. Y., & Vikram, P. R. H. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01013-x · Cited by 25

Impact of dyslipidemia on the cumulative pregnancy outcomes after first ovarian stimulation

Jiang, X., Lu, X., Cai, M., Liu, Y., & Guo, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.915424 · Cited by 24

Transcutaneous auricular vagus nerve stimulation as a potential novel treatment for polycystic ovary syndrome

Zhang, S., He, H., Wang, Y., Wang, X., & Liu, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-34746-z · Cited by 26

Management of Polycystic Ovary Syndrome in India

Malik, S., Jain, K., Talwar, P., Prasad, S., Dhorepatil, B., Devi, G., Khurana, A., Bhatia, V., Chandiok, N., Kriplani, A., et al. (2014) · Fertility Science and Research · doi:10.4103/2394-4285.146798 · Cited by 26

Endothelial Dysfunction in a Rat Model of PCOS: Evidence of Increased Vasoconstrictor Prostanoid Activity

Keller, J., Mandalà, M., Casson, P. R., & Osol, G. (2011) · Endocrinology · doi:10.1210/en.2011-1424 · Cited by 24

The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome

Yang, H., Ma, Y., Lu, X., Liang, X., Suo, Y.-J., Huang, Z., Lü, D., Qin, Y., & Luo, Z. (2015) · Annales d Endocrinologie · doi:10.1016/j.ando.2015.08.002 · Cited by 24

Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study

Kyrkou, G. A., Trakakis, E., Attilakos, A., Panagopoulos, P., Chrelias, C. G., Papadimitriou, A., Vaggopoulos, V., Alexiou, E., Mastorakos, G., Lykeridou, A., et al. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3964-y · Cited by 24

The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome

Sathyapalan, T., Hobkirk, J., Javed, Z., Carroll, S., Coady, A., Pemberton, P. W., Smith, A., Cianflone, K., & Atkin, S. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00394 · Cited by 24

Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome.

Carmina, E. (2013) · PubMed · doi:10.3275/8882 · Cited by 24

Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular Risk

Singh, P., Covassin, N., Marlatt, K. L., Gadde, K. M., & Heymsfield, S. B. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210014 · Cited by 44

Follicle-Stimulating Hormone Levels and Subclinical Atherosclerosis in Older Postmenopausal Women

Bertone‐Johnson, E. R., Virtanen, J. K., Nurmi, T., NISKANEN, L. K., Mursu, J., Voutilainen, S., Ronkainen, K., Kauhanen, J., & Tuomainen, T. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx174 · Cited by 25

Impact of hormonal contraception and weight loss on high‐density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome

Dokras, A., Playford, M. P., Kris‐Etherton, P. M., Kunselman, A. R., Stetter, C., Williams, N. I., Gnatuk, C. L., Estes, S. J., Sarwer, D. B., Allison, K. C., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13310 · Cited by 24

Metabolic, Hormonal, Immunologic, and Genetic Factors Associated With the Incidence of Thyroid Disorders in Polycystic Ovarian Syndrome Patients

Singh, J., Wong, H., Ahluwalia, N., Go, R. M., & Guerrero-Go, M. A. (2020) · Cureus · doi:10.7759/cureus.11681 · Cited by 24

Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome

Gomez-Meade, C. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i3.64 · Cited by 22

Phenotypic Expression of Polycystic Ovary Syndrome in South Asian Women

Mehta, J. M., Kamdar, V. V., & Dumesic, D. A. (2013) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318280a30f · Cited by 23

Untitled work

(2014) · doi:10.1007/978-1-4471-2789-5_13 · Cited by 23

Acupuncture or metformin to improve insulin resistance in women with polycystic ovary syndrome: study protocol of a combined multinational cross sectional case-control study and a randomised controlled trial

Stener‐Victorin, E., Zhang, H., Li, R., Fridén, C., Li, D., Wang, W., Wang, H., Chang, C., Shi, L., Huo, Z., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024733 · Cited by 23

Improved diagnostic performance for the diagnosis of polycystic ovary syndrome using age-stratified criteria

Ahmad, A., Quinn, M. M., Kao, C., Greenwood, E. A., Cedars, M. I., & Huddleston, H. G. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.044 · Cited by 23

Exploring the Pharmacological Mechanism of Quercetin-Resveratrol Combination for Polycystic Ovary Syndrome: A Systematic Pharmacological Strategy-Based Research

Yang, K., Zeng, L., Bao, T., Long, Z., & Jin, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-54408-3 · Cited by 23

The diagnosis of PCOS in young infertile women according to different diagnostic criteria: the role of serum anti-Müllerian hormone

Casadei, L., Fanisio, F., Sorge, R. P., Collamarini, M., Piccolo, E., & Piccione, E. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4803-8 · Cited by 24

Heart health in polycystic ovary syndrome: time to act on the data

Dokras, A. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.014 · Cited by 22

Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis.

Zadehmodarres, S., Heidar, Z., Razzaghi, Z., Farsangi, L. E., Soltanzadeh, K., & Abed, F. (2015) · PubMed Central · Cited by 22

No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen‐secreting tumours

Pelusi, C., Forlani, G., Zanotti, L., Gambineri, A., & Pasquali, R. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04438.x · Cited by 22

Dietary Carbohydrate Intake Does Not Impact Insulin Resistance or Androgens in Healthy, Eumenorrheic Women

Sjaarda, L. A., Schisterman, E. F., Schliep, K. C., Plowden, T. C., Zarek, S. M., Yeung, E. H., Wactawski‐Wende, J., & Mumford, S. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1957 · Cited by 28

Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews

Tay, C. T., Joham, A. E., Hiam, D., Gadalla, M. A., Pundir, J., Thangaratinam, S., Teede, H. J., & Moran, L. (2018) · Clinical Endocrinology · doi:10.1111/cen.13753 · Cited by 23

Differential association of DENND1A genetic variants with polycystic ovary syndrome in Tunisian but not Bahraini Arab women

Dallel, M., Sarray, S., Douma, Z., Hachani, F., Al-Ansari, A. K., Letaifa, D. B., Mahjoub, T., & Almawi, W. Y. (2018) · Gene · doi:10.1016/j.gene.2018.01.028 · Cited by 23

Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome

Dargham, S. R., Elshewehy, A. M. M., Dakroury, Y., Kilpatrick, E. S., & Atkin, S. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-21987-6 · Cited by 21

Ethinyl Estradiol-Cyproterone Acetate Versus Low-Dose Pioglitazone-Flutamide-Metformin for Adolescent Girls with Androgen Excess: Divergent Effects on CD163,TWEAK Receptor,ANGPTL4, and LEPTIN Expression in Subcutaneous Adipose Tissue

Díaz, M., Chacón, M. R., López-Bermejo, A., Maymó-Masip, E., Salvador, C., Vendrell, J., de Zegher, F., & Ibáñez, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1754 · Cited by 21

Testosterone is associated with insulin resistance index independently of adiposity in women with polycystic ovary syndrome

Luotola, K., Piltonen, T. T., Puurunen, J., Morin-Papunen, L. C., & Tapanainen, J. S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1342793 · Cited by 21

Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS)

Salem, A. B., Ajina, M., Suissi, M., Daher, H. S., Almawi, W. Y., & Mahjoub, T. (2013) · Gene · doi:10.1016/j.gene.2013.09.104 · Cited by 21

Dysglycemia, Not Altered Sex Steroid Hormones, Affects Cognitive Function in Polycystic Ovary Syndrome

Jarrett, B. Y., Vantman, N., Mergler, R. J., Brooks, E. D., Pierson, R. A., Chizen, D. R., & Lujan, M. E. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00112 · Cited by 21

Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis

Kazemi, M., Kim, J. Y., Parry, S. A., Azziz, R., & Lujan, M. E. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.12.019 · Cited by 21

Cardiovascular and metabolic actions of the androgens: Is testosterone a Janus-faced molecule?

Stallone, J. N., & Oloyo, A. K. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115347 · Cited by 22

A new model for predicting the occurrence of polycystic ovary syndrome: Based on data of tongue and pulse

Wang, W., Zeng, W., He, S., Shi, Y., Chen, X., Tu, L., Yang, B., Xu, J., & Yin, X. (2023) · Digital Health · doi:10.1177/20552076231160323 · Cited by 21

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes

Moulana, M. (2023) · Life · doi:10.3390/life13041010 · Cited by 23

Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review

Choudhari, R. G., Tayade, S. A., Tiwari, A., & Satone, P. D. (2024) · Cureus · doi:10.7759/cureus.58733 · Cited by 29

Sex differences in stroke across the lifespan: The role of T lymphocytes

Bravo-Alegria, J. B., McCullough, L. D., & Liu, F. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.009 · Cited by 21

Adropin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with lipoprotein lipid profiles

Bousmpoula, A., Kouskouni, E. E., Benidis, E., Demeridou, S., Kapeta-Kourkouli, R., Chasiakou, A., & Baka, S. G. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1379498 · Cited by 21

Hemostatic and Fibrinolytic Abnormalities in Polycystic Ovary Syndrome

Zoppini, G., Bonora, E., Moghetti, P., & Targher, G. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1384512 · Cited by 21

Neuronal androgen receptor: molecular gateway to polycystic ovary syndrome

Abbott, D. H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703436114 · Cited by 20

Is cardiorespiratory fitness impaired in PCOS women? A review of the literature

Donà, S., Bacchi, E., & Moghetti, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0599-1 · Cited by 20

What does a diagnostic label of ‘polycystic ovary syndrome’ really mean in adolescence? a review of current practice recommendations

Morris, S., Grover, S. R., & Sabin, M. A. (2015) · Clinical Obesity · doi:10.1111/cob.12123 · Cited by 20

Comprehensive Meta-Analysis of Functional and Structural Markers of Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome

Sun, D., Wu, Y., Ding, M., & Zhu, F. (2022) · Angiology · doi:10.1177/00033197211072598 · Cited by 20

Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome

Livadas, S., Paparodis, R. D., Anagnostis, P. G., Gambineri, A., Μacut, D., Petrović, T., Yıldız, B. O., Micić, D., Mastorakos, G. P., & Μacut, D. (2023) · Diagnostics · doi:10.3390/diagnostics13122067 · Cited by 23

Polycystic ovary syndrome: associations with cardiovascular disease

Benham, J. L., Goldberg, A., Teede, H. J., & Tay, C. T. (2023) · Climacteric · doi:10.1080/13697137.2023.2282689 · Cited by 20

Diagnostic accuracy of oral glucose tolerance tests, fasting plasma glucose and haemoglobin A1c for type 2 diabetes in women with polycystic ovary syndrome: A systematic review and meta-analysis

Belsti, Y., Enticott, J., Azumah, R., Tay, C. T., Moran, L., Ronald, C. W., Joham, A. E., Laven, J. S. E., Teede, H. J., & Mousa, A. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.102970 · Cited by 27

Bone mineral density and vitamin D in PCOS and hirsutism

Glintborg, D., Hermann, A. P., & Andersen, M. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2013.827384 · Cited by 20

Is Insulin Resistance an Intrinsic Defect in Asian Polycystic Ovary Syndrome?

Lee, H., Oh, J. Y., Sung, Y., & Chung, H. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.3.609 · Cited by 20

Reduced Estradiol-Induced Vasodilation and Poly-(ADP-Ribose) Polymerase (PARP) Activity in the Aortas of Rats with Experimental Polycystic Ovary Syndrome (PCOS)

Masszi, G., Horvath, E. M., Tarszabó, R., Benkő, R., Novák, Á., Buday, A., Tõkés, A., Nádasy, G. L., Hamar, P., Benyó, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055589 · Cited by 20

Serum Fetuin-A levels in women with polycystic ovary syndrome

Gülhan, İ., Bozkaya, G., Öztekin, D. C., Uyar, İ., Kebapçılar, A. G., & Pamuk, B. Ö. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2494-0 · Cited by 21

Prescription of antidepressants is increased in D anish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population‐based cohort study

Altinok, M. L., Glintborg, D., Christensen, R. D., Hallas, J., & Andersen, M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12365 · Cited by 20

Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome

Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Delkos, D., Tsourdi, E. A., & Panidis, D. (2013) · HORMONES · doi:10.14310/horm.2002.1444 · Cited by 20

Association of TLR2 S450S and ICAM1 K469E polymorphisms with polycystic ovary syndrome (PCOS) and obesity

Ojeda, M. O., Martínez-García, M. Á., Alpañés, M., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.09.072 · Cited by 20

Accelerated Episodic Luteinizing Hormone Release Accompanies Blunted Progesterone Regulation in PCOS-like Female Rhesus Monkeys (Macaca Mulatta) Exposed to Testosterone during Early-to-Mid Gestation

Abbott, D. H., Vepraskas, S., Horton, T. H., Terasawa, E., & Levine, J. E. (2018) · Neuroendocrinology · doi:10.1159/000490570 · Cited by 21

Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Khatlani, K., Njike, V., & Costales, V. C. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0049 · Cited by 20

Serum Anti-Müllerian hormone in polycystic ovary syndrome and its relationship with insulin resistance, lipid profile and adiponectin

Jelani, A. M., Jun, T., Omar, J., Rahim, R. A., & Yaacob, N. M. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_305_19 · Cited by 21

Metabolic Disturbance in PCOS: Clinical and Molecular Effects on Skeletal Muscle Tissue

Dantas, W. S., Gualano, B., Rocha, M. P., Barcellos, C. R. G., Yance, V. D. R. V., & Marcondes, J. A. M. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/178364 · Cited by 22

Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome

Kushnir, V. A., Halevy, N., Barad, D. H., Albertini, D. F., & Gleicher, N. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0175-x · Cited by 20

Polycystic Ovary Syndrome in Adolescents

Horn, M., & Geraci, S. A. (2013) · Southern Medical Journal · doi:10.1097/smj.0000000000000003 · Cited by 20

Effects of exogenous adiponectin supplementation in early pregnant PCOS mice on the metabolic syndrome of adult female offspring

Zuo, M., Liao, G., Zhang, W., Xu, D., Lü, J., Tang, M., Yan, Y., Hong, C., & Wang, Y. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-020-00755-z · Cited by 19

Association of Subclinical Hypothyroidism with Present and Absent Anti-Thyroid Antibodies with PCOS Phenotypes and Metabolic Profile

Gawron, I. M., Baran, R., Derbisz, K., & Jach, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061547 · Cited by 20

Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk

Quinn, M. M., Kao, C., Ahmad, A., Lenhart, N. J., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.06.026 · Cited by 20

Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes

Ortiz-Flores, A. E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1528231 · Cited by 20

Circulating Endothelial Microparticles Reduce in Concentration Following an Exercise Programme in Women With Polycystic Ovary Syndrome

Kirk, R. J., Madden, L. A., Peart, D. J., Aye, M. M., Atkin, S. L., & Vince, R. V. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00200 · Cited by 19

Polycystic ovary syndrome and endothelial dysfunction: A potential role for soluble lectin-like oxidized low density lipoprotein receptor-1

Öncül, M., Albayrak, M., Sözer, V., Karakuş, B., Gelışgen, R., Karataş, S., Şimşek, G., & Uzun, H. (2020) · Reproductive Biology · doi:10.1016/j.repbio.2020.04.006 · Cited by 19

Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls

Reynolds-May, M. F., Kenna, H. A., Marsh, W., Stemmle, P. G., Wang, P. W., Ketter, T. A., & Rasgon, N. (2013) · Bipolar Disorders · doi:10.1111/bdi.12149 · Cited by 19

Association between Follicular Fluid Leptin and Serum Insulin Levels in Nonoverweight Women with Polycystic Ovary Syndrome

Garruti, G., Palo, R. D., Rotelli, M. T., Nocera, S., Totaro, I., Nardelli, C., Panzarino, M., Vacca, M., Selvaggi, L. E., & Giorgino, F. (2014) · BioMed Research International · doi:10.1155/2014/980429 · Cited by 19

CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes

Moro, F., Morciano, A., Tropea, A., Sagnella, F., Palla, C., Scarinci, E., Cosentino, N., Niccoli, G., Liuzzo, G., Crea, F., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.015 · Cited by 19

Pregnancy complications and metabolic disease in women with clomiphene citrate-resistant anovulation randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotropins: a 10-year follow-up

Nahuis, M. J., Oude Lohuis, E. J., Bayram, N., Hompes, P. G. A., Oosterhuis, G. J. E., van der Veen, F., Mol, B. W. J., & van Wely, M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.09.004 · Cited by 18

Circulating Vascular Progenitor Cells and Central Arterial Stiffness in Polycystic Ovary Syndrome

Dessapt-Baradez, C., Reza, M., Sivakumar, G. S., Hernández-Fuentes, M. P., Markakis, K., Gnudi, L., & Karalliedde, J. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020317 · Cited by 18

Sex hormones and the risk of myocardial infarction in women and men: a prospective cohort study in the UK Biobank

Harris, K., Peters, S. A. E., & Woodward, M. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00546-3 · Cited by 18

Targets to treat androgen excess in polycystic ovary syndrome

Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1075511 · Cited by 18

Interventions for the metabolic dysfunction in polycystic ovary syndrome

Bozdag, G., & Yildiz, B. O. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.008 · Cited by 18

Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome

Koiou, E., Τζιόμαλος, Κ., Dinas, K. D., Katsikis, I., Kandaraki, E., Tsourdi, E. A., Mavridis, S., & Panidis, D. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0023 · Cited by 18

Cangfu daotan decoction for polycystic ovary syndrome

Park, H.-R., Kim, J.-H., Lee, D., & Jo, H.-G. (2019) · Medicine · doi:10.1097/md.0000000000017321 · Cited by 19

Chronic inflammation in polycystic ovary syndrome: A case–control study using multiple markers

Goswami, S., Choudhuri, S., Bhattacharya, B., Bhattacharjee, R., Roy, A., Mukhopadhyay, S., Ghosh, S. K., & Chowdhury, S. (2021) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v19i4.9057 · Cited by 18

Postmenopausal hyperandrogenism

Yoldemir, T. (2021) · Climacteric · doi:10.1080/13697137.2021.1915273 · Cited by 18

Affect-regulated exercise: an alternative approach for lifestyle modification in overweight/obese women with polycystic ovary syndrome

Costa, E. C., de Sá, J. C. F., Costa, I. B. B., Meireles, R. D. S. R. V., Lemos, T. M. A. M., Elsangedy, H. M., Krinski, K., & Azevedo, G. D. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1092132 · Cited by 21

Metformin in women with PCOS, CONS

Misso, M. L., & Teede, H. J. (2014) · Endocrine · doi:10.1007/s12020-014-0394-8 · Cited by 18

Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome

Gateva, A., & Kamenov, Z. A. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.05.037 · Cited by 18

Effects of Carnitine Administration on Carotid Intima-media Thickness and Inflammatory Factors in Patients with Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial

Talari, H. R., Azad, Z. J., Hamidian, Y., Samimi, M., Gilasi, H. R., Afshar, F. E., Ostadmohammadi, V., & Asemi, Z. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_2_18 · Cited by 18

The Phenotypes of Polycystic Ovary Syndrome Defined by the 1990 Diagnostic Criteria Are Associated with Higher Serum Vaspin Levels than the Phenotypes Introduced by the 2003 Criteria

Koiou, E., Dinas, K. D., Τζιόμαλος, Κ., Toulis, K. A., Kandaraki, E., Kalaitzakis, E., Katsikis, I., & Panidis, D. (2011) · Obesity Facts · doi:10.1159/000327935 · Cited by 18

Diagnosing Dysglycemia in Adolescents With Polycystic Ovary Syndrome

Gooding, H. C., Milliren, C., St. Paul, M., Mansfield, M. J., & DiVasta, A. (2014) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2013.12.020 · Cited by 17

Chemerin and Polycystic Ovary Syndrome: A Comprehensive Review of Its Role as a Biomarker and Therapeutic Target

Palomba, S., Seminara, G., Costanzi, F., Caserta, D., & Aversa, A. (2024) · Biomedicines · doi:10.3390/biomedicines12122859 · Cited by 18

Polycystic ovary syndrome and cardiovascular risk. Could trimethylamine N-oxide (TMAO) be a major player? A potential upgrade forward in the DOGMA theory

Annunziata, G., Ciampaglia, R., Capó, X., Guerra, F., Sureda, A., Tenore, G. C., & Novellino, E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112171 · Cited by 18

Clinical guidelines «Polycystic Ovary Syndrome»

Adamyan, L. V., Andreeva, E. N., Absatarova, Y. S., Grigoryan, O. R., Dedov, I. I., Mel'nichenko, G. A., Сутурина, Л. В., Филиппов, О. С., Sheremetyeva, E. V., Евгеньевна, Ч. Г., et al. (2022) · Problems of Endocrinology · doi:10.14341/probl12874 · Cited by 24

Polycystic ovary syndrome: implications of metabolic dysfunction

de Ávila, M. A. P., Bruno, R. V., Barbosa, F. C., de Andrade, F. C., Silva, A. C. D. O. E., & Nardi, A. E. (2014) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/s0100-69912014000200006 · Cited by 39

Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescent Females

Ebersole, A. M., & Bonny, A. E. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000538 · Cited by 17

Hashimoto’s thyroiditis might increase polycystic ovary syndrome and associated comorbidities risks in Asia

Ho, C.-W., Chen, H.-H., Hsieh, M., Chen, C., Hsu, S.-P., Yip, H., & Kao, C. (2020) · Annals of Translational Medicine · doi:10.21037/atm-19-4763 · Cited by 17

Impact of Subclinical Hypothyroidism on Reproductive and Metabolic Parameters in Polycystic Ovary Syndrome – A Cross-sectional Study from Bangladesh

Kamrul-Hasan, A. B. M., Aalpona, F. T. Z., & Selim, S. (2020) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2020.16.2.156 · Cited by 17

Dificuldades e armadilhas no diagnóstico da síndrome dos ovários policísticos

Marcondes, J. A. M., Barcellos, C. R. G., & Rocha, M. P. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000100002 · Cited by 17

Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors

Barcellos, C. R. G., Rocha, M. P., Hayashida, S. A. Y., Dantas, W. S., Yance, V. D. R. V., & Marcondes, J. A. M. (2015) · HORMONES · doi:10.14310/horm.2002.1584 · Cited by 17

Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment

Daskalopoulos, G. N., Karkanaki, A., Piouka, A., Πράπας, Ν., Panidis, D., Gkeleris, P., & Athyros, V. G. (2015) · Current Vascular Pharmacology · doi:10.2174/1567201812666150120163025 · Cited by 17

A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome

Rezaee, M., Asadi, N., Pouralborz, Y., Ghodrat, M., & Habibi, S. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2016.07.001 · Cited by 19

Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?

Dube, R. (2016) · Avicenna Journal of Medicine · doi:10.4103/2231-0770.191445 · Cited by 17

Echocardiographic evaluation of diastolic functions in patients with polycystic ovary syndrome: A comperative study of diastolic functions in sub-phenotypes of polycystic ovary syndrome

Yıldırım, E., Karabulut, O., Yüksel, U. Ç., Çeli̇k, M., Buğan, B., Gökoğlan, Y., Ulubay, M., Güngör, M., & Köklü, M. (2017) · Cardiology Journal · doi:10.5603/cj.a2017.0032 · Cited by 17

The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment

Baldani, D. P., Skrgatic, L., Ougouag, R., & Kasum, M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1381681 · Cited by 17

Salivary cortisol and cortisone responses to short-term psychological stress challenge in late adolescent and young women with different hyperandrogenic states

Mezzullo, M., Fanelli, F., Dalmazi, G. D., Fazzini, A., Gasparini, D. I., Mastroroberto, M., Guidi, J., Morselli‐Labate, A. M., Pasquali, R., Pagotto, U., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.02.022 · Cited by 17

Utility of the Oral Glucose Tolerance Test to Assess Glucose Abnormalities in Adolescents with Polycystic Ovary Syndrome

Coles, N., Bremer, K., Kives, S., Zhao, X., & Hamilton, J. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.06.004 · Cited by 16

Evaluation of Cardiovascular Disease Risk in Women having Poly Cystic Ovarian Syndrome

Rao, G. (2021) · Journal of Cardiology and Cardiovascular Research · doi:10.37191/mapsci-jccr-2(3)-036

Polycystic ovary syndrome: associations with cardiovascular disease

Benham, J. L., Goldberg, A., Teede, H. J., & Tay, C. T. (2023) · Climacteric · doi:10.1080/13697137.2023.2282689 · Cited by 20

Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)

Geraci, G., Riccio, C., Oliva, F. G., Gabrielli, D., Colivicchi, F., Grimaldi, M., Facchinetti, F., & Unfer, V. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1520490 · Cited by 19

Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today??s Clinician

Lorenz, L. B., & Wild, R. A. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31802f5197 · Cited by 43

Polycystic Ovary Syndrome and Cardiovascular Risk

Moore, M. E., Hirani, R., Khessib, S., Chirumamilla, A. P., Frishman, W. H., & Etienne, M. (2026) · Cardiology in Review · doi:10.1097/crd.0000000000001453